GlassScriptPhysician profile
Jason Tran
NPI 1922480904
$2,782.63
in general payments reported to CMS, 2019-2025
25 companies · $499 in 2025
The $499 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $629 · 2020: $160 · 2021: $348 · 2022: $214 · 2023: $414 · 2024: $519 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,315 · Entertainment: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,314.51 |
| Entertainment | $117.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $562.87 | 2019-2023 | Cequa, Bromsite, Xelpros |
| Glaukos Corporation | $255.23 | 2024-2025 | Istent Infinite, Idosetr, Idose |
| Alcon Vision LLC | $208.39 | 2019-2025 | Tryptyr |
| Biotissue Holdings INC. | $198.12 | 2024 | |
| Kala Pharmaceuticals, INC. | $183.52 | 2021-2022 | |
| Tarsus Pharmaceuticals, INC. | $158.77 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $135.19 | 2022-2024 | Tyrvaya |
| Allergan, INC. | $129.57 | 2019-2021 | |
| Abbvie INC. | $128.25 | 2023-2025 | Alphagan P, Lumigan, Durysta |
| Optos, INC. | $117.74 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Shire North American Group INC | $109.71 | 2019 | |
| Bausch & Lomb Americas INC. | $108.32 | 2022-2024 | Miebo, Vyzulta, Xiidra |
| Harrow Eye, LLC | $88.10 | 2025 | Vevye |
| Johnson & Johnson Surgical Vision, INC. | $81.36 | 2019 | |
| Dompe US, INC. | $69.50 | 2024-2025 | Oxervate |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $42.05 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $39.75 | 2020-2021 | |
| Johnson & Johnson Vision Care, INC. | $30.86 | 2019 | |
| Mallinckrodt Hospital Products INC. | $26.10 | 2020 | |
| Mallinckrodt Enterprises LLC | $21.17 | 2019 | |
| Omeros Corporation | $19.26 | 2019 | |
| Dermira, INC. | $18.75 | 2019 | |
| Rxsight INC | $17.67 | 2020-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Thea Pharma INC. | $16.20 | 2022 | |
| Eyevance Pharmaceuticals LLC | $16.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.